Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10838
Title: Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Authors: Lawrentschuk, Nathan L ;Lee, Fook-Thean;Jones, Gareth;Rigopoulos, Angela;Mountain, Angela;O'Keefe, Graeme J;Papenfuss, Anthony T;Bolton, Damien M;Davis, Ian D;Scott, Andrew M
Affiliation: University of Melbourne Department of Surgery, Austin Hospital, Melbourne, Victoria, Australia. nathan.lawrentschuk@uhn.on.ca
Issue Date: 12-Jun-2009
Citation: Urologic Oncology 2009; 29(4): 411-20
Abstract: In tumors, hypoxia stimulates angiogenesis and correlates with treatment resistance and poor prognosis. We have previously demonstrated hypoxia in human renal cell carcinoma (RCC) via direct oxygen probe measurements. Carbonic anhydrase IX (CA IX) is a protein stimulated by hypoxia and involved in angiogenesis, and is a potential tumor target for imaging and therapies using cG250, a monoclonal antibody that recognizes CAIX. Our objectives were to characterize intratumoral hypoxia in a human RCC xenograft model using oxygen probe measurements; investigate if (124)I-cG250 targets RCC correlating uptake on noninvasive positron emission tomography-computerized tomography (PET-CT) against traditional biodistribution studies, and investigate CAIX expression in this RCC model.BALB/c nude mice had human RCC (SK-RC-52) subcutaneously xenografted with oxygen levels measured by probe. Positron emission tomography (PET/CT) and biodistribution studies ((124)I-cG250) were correlated with oxygen measurements. Immunohistochemistry and autoradiography were performed on selected tumors to confirm CAIX expression.Oxygen tension in normal tissue (muscle) was 35.08 ± 2.41 mmHg (mean ± 95% CI), significantly greater compared to xenograft SK-RC-52 tumors at 5.02 ± 1.12 mmHg. Biodistribution studies of (124)I-cG250 demonstrated isotope uptake in SK-RC-52 xenografts peaking at 23.45 ± 5.07% ID/g (mean ± SD) 48 hours after antibody injection, which was maintained for a further 2 days (19.43 ± 4.31 and 10.64 ± 5.64 % ID/g, respectively). PET studies demonstrated excellent localization of (124)I-cG250 in tumor, and a significant correlation between SUVmean, SUVmax, and %/ID (124)I-cG250. CAIX expression was present in all groups studied but there was no significant correlation between it and any oxygen parameter studied.Intratumoral hypoxia does exist within a human RCC xenograft model using invasive oxygen probe measurements. (124)I-cG250 targets RCC with correlation between uptake on noninvasive PET-CT studies and traditional biodistribution studies opening the possibility of using PET/CT in future studies. Finally, CAIX expression was not related to hypoxia in this model, supporting the hypothesis that cell lines may subvert known hypoxia mechanisms in hypoxic environments.
Internal ID Number: 19523858
URI: http://ahro.austin.org.au/austinjspui/handle/1/10838
DOI: 10.1016/j.urolonc.2009.03.028
URL: http://www.ncbi.nlm.nih.gov/pubmed/19523858
Type: Journal Article
Subjects: Animals
Anoxia
Antibodies, Monoclonal.immunology.pharmacokinetics
Antigens, Neoplasm.biosynthesis
Autoradiography
Carbonic Anhydrases.biosynthesis
Carcinoma, Renal Cell.metabolism.pathology.radionuclide imaging
Cell Line, Tumor
Humans
Immunohistochemistry
Iodine Radioisotopes.pharmacokinetics
Kidney Neoplasms.metabolism.pathology.radionuclide imaging
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation
Oxygen.metabolism
Positron-Emission Tomography.methods
Tissue Distribution
Transplantation, Heterologous
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.